Christopher Salerno to Follow-Up Studies
This is a "connection" page, showing publications Christopher Salerno has written about Follow-Up Studies.
Connection Strength
0.334
-
INTERMACS profiles and modifiers: Heterogeneity of patient classification and the impact of modifiers on predicting patient outcome. J Heart Lung Transplant. 2016 Apr; 35(4):440-8.
Score: 0.082
-
Early elevations in pump power with the HeartMate II left ventricular assist device do not predict late adverse events. J Heart Lung Transplant. 2014 Aug; 33(8):809-15.
Score: 0.073
-
Five-Year Outcomes in Patients With Fully Magnetically Levitated vs Axial-Flow Left Ventricular Assist Devices in the MOMENTUM 3 Randomized Trial. JAMA. 2022 09 27; 328(12):1233-1242.
Score: 0.033
-
Impact of left ventricular assist device implantation on mitral regurgitation: An analysis from the MOMENTUM 3 trial. J Heart Lung Transplant. 2020 06; 39(6):529-537.
Score: 0.028
-
A tale of the twist in the outflow graft: An analysis from the MOMENTUM 3 trial. J Heart Lung Transplant. 2018 11; 37(11):1281-1284.
Score: 0.025
-
Surgical therapy for pulmonary aspergillosis in immunocompromised patients. Ann Thorac Surg. 1998 May; 65(5):1415-9.
Score: 0.024
-
Temporal Differences in Outcomes During Long-Term Mechanical Circulatory Support. J Card Fail. 2017 Dec; 23(12):852-858.
Score: 0.023
-
Outcomes of Patients Receiving Temporary Circulatory Support Before Durable Ventricular Assist Device. Ann Thorac Surg. 2017 Jan; 103(1):106-112.
Score: 0.022
-
The HVAD Left Ventricular Assist Device: Risk Factors for Neurological Events and Risk Mitigation Strategies. JACC Heart Fail. 2015 Oct; 3(10):818-28.
Score: 0.020
-
Pulmonary resection for metastatic breast cancer. Arch Surg. 1992 Nov; 127(11):1282-4.
Score: 0.004